Cargando…
Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability
INTRODUCTION: Aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) plays a major role in improving early rheumatoid arthritis (RA) patient outcomes. Persistence and adherence with medication occurs variably (20% to 70%). The objectives of the study were to determine medication pe...
Autores principales: | Pascual-Ramos, Virginia, Contreras-Yáñez, Irazú, Villa, Antonio R, Cabiedes, Javier, Rull-Gabayet, Marina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688260/ https://www.ncbi.nlm.nih.gov/pubmed/19228421 http://dx.doi.org/10.1186/ar2620 |
Ejemplares similares
-
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2015) -
Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective
por: Pascual-Ramos, Virginia, et al.
Publicado: (2013) -
Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017) -
Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017) -
Validation of a risk perception questionnaire developed for patients with rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2019)